WIRB, Huron align as clinical research industry challenges mount

By Melissa Fassbender

- Last updated on GMT

Increasing costs and regulatory changes are among several of the challenges facing the clinical research industry. (Image: iStock/Radachynskyi)
Increasing costs and regulatory changes are among several of the challenges facing the clinical research industry. (Image: iStock/Radachynskyi)

Related tags Medicine

WIRB-Copernicus Group (WIRB) and Huron have announced an alliance to support research programs in the face of heightened expectations from industry sponsors.

Nick Slack, MBE, EVP and chief growth officer at WIRB-Copernicus Group told us the rationale behind the alliance is to help research institutions adapt to “a number ofchallenging market forces​” currently applying increased pressure on institutions.

Looming NIH budget cuts, mounting performance expectations from industry sponsors, and regulatory changes are forcing institutions to rapidly adapt to a more competitive clinical research environment​,” Slack explained.

Through the alliance, the ethical research review provider and the global professional services firm aim to help institutions attract externally-funded research, conduct research with improved financial management, and streamline administrative burdens for researchers and industry sponsors.

With the combined experience and expertise of WIRB and Huron, institutions will develop stronger research programs, provide their patients with more opportunities to participate in research, and fuel the medical research enterprise with renewed vigor​,” added Slack.

The relationship between WIRB and Huron is a long-term, exclusive alliance.

Each organization is substantially committed to ensuring that academic medical centers and hospitals have the necessary knowledge, support, and resources at their disposal to thrive in the face of new challenges​,” Slack said.

Related topics Clinical Development

Related news